Lipinski's Rule of Five is a set of guidelines designed to predict the oral bioavailability of a compound, particularly in the context of drug development. Formulated by Christopher A. Lipinski in 1997, these rules help assess whether a small molecule is likely to have favorable pharmacokinetics in humans (i.e., absorption, distribution, metabolism, and excretion or ADME properties).

Articles by others on the same topic (0)

There are currently no matching articles.